miR-512-5 p induces apoptosis and inhibits glycolysis by targeting p 21 in non-small cell lung cancer cells
暂无分享,去创建一个
S. Ren | Caicun Zhou | G. Gao | Xiufang Yang | L. Yao | Yangang Huang | Kaili Chu | Wu Hai
[1] Alessandro Laganà,et al. MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLC , 2015, Proceedings of the National Academy of Sciences.
[2] M. Kerin,et al. MicroRNA-10a is reduced in breast cancer and regulated in part through retinoic acid , 2015, BMC Cancer.
[3] G. Goodall,et al. MicroRNA networks regulated by all-trans retinoic acid and Lapatinib control the growth, survival and motility of breast cancer cells , 2015, Oncotarget.
[4] S. Ren,et al. Inhibition of RAC1-GEF DOCK3 by miR-512-3p contributes to suppression of metastasis in non-small cell lung cancer. , 2015, The international journal of biochemistry & cell biology.
[5] A. Jemal,et al. Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.
[6] F. Lo‐Coco,et al. Retinoic acid receptors: from molecular mechanisms to cancer therapy. , 2015, Molecular aspects of medicine.
[7] S. Tavazoie,et al. Extracellular Metabolic Energetics Can Promote Cancer Progression , 2015, Cell.
[8] E. Domany,et al. Reactivation of epigenetically silenced miR-512 and miR-373 sensitizes lung cancer cells to cisplatin and restricts tumor growth , 2015, Cell Death and Differentiation.
[9] Yanxia Sun,et al. Retraction Note to: Text mining and network analysis of molecular interaction in non-small cell lung cancer by using natural language processing , 2014, Molecular Biology Reports.
[10] R. Agarwal,et al. Energy deprivation by silibinin in colorectal cancer cells , 2013, Autophagy.
[11] David I. Smith,et al. Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm , 2012, Cell cycle.
[12] Y. Huang,et al. MicroRNA-212 displays tumor-promoting properties in non-small cell lung cancer cells and targets the hedgehog pathway receptor PTCH1 , 2012, Molecular biology of the cell.
[13] J. Ricci,et al. Cancer metabolism: current perspectives and future directions , 2012, Cell Death and Disease.
[14] A. Caro-Maldonado,et al. Sugar-free approaches to cancer cell killing , 2011, Oncogene.
[15] B. Löwenberg,et al. Therapeutic advances in acute myeloid leukemia. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] K. Niederreither,et al. A retinoic acid-dependent network in the foregut controls formation of the mouse lung primordium. , 2010, The Journal of clinical investigation.
[17] T. Hibi,et al. Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells , 2009, Oncogene.
[18] Anindya Dutta,et al. p21 in cancer: intricate networks and multiple activities , 2009, Nature Reviews Cancer.
[19] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[20] Russell G. Jones,et al. Tumor suppressors and cell metabolism: a recipe for cancer growth. , 2009, Genes & development.
[21] J. Mendell. miRiad Roles for the miR-17-92 Cluster in Development and Disease , 2008, Cell.
[22] A. Gartel. The conflicting roles of the cdk inhibitor p21(CIP1/WAF1) in apoptosis. , 2005, Leukemia research.
[23] F. Slack,et al. RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.
[24] J. Welsh,et al. Vitamin D Receptor and p21/WAF1 Are Targets of Genistein and 1,25-Dihydroxyvitamin D3 in Human Prostate Cancer Cells , 2004, Cancer Research.
[25] L. Thompson,et al. Lignans and Tamoxifen, Alone or in Combination, Reduce Human Breast Cancer Cell Adhesion, Invasion and Migration in vitro , 2003, Breast Cancer Research and Treatment.
[26] I. Roninson. Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. , 2002, Cancer letters.
[27] G. Dotto,et al. p21(WAF1/Cip1): more than a break to the cell cycle? , 2000, Biochimica et biophysica acta.
[28] H. Gascan,et al. Functional Interaction of STAT3 Transcription Factor with the Cell Cycle Inhibitor p21 WAF1/CIP1/SDI1 * , 2000, The Journal of Biological Chemistry.
[29] H. Yoshikawa,et al. Reciprocal Regulation via Protein-Protein Interaction between c-Myc and p21 cip1/waf1/sdi1 in DNA Replication and Transcription* , 2000, The Journal of Biological Chemistry.
[30] James M. Roberts,et al. CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.
[31] I. Kanazawa,et al. Bcl-2 inhibits retinoic acid-induced apoptosis during the neural differentiation of embryonal stem cells , 1996, The Journal of cell biology.
[32] Stephen J. Elledge,et al. Mice Lacking p21 CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control , 1995, Cell.
[33] G. Hannon,et al. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair , 1994, Nature.
[34] S. Elledge,et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.
[35] E. Gócza,et al. The miR-290-295 cluster promotes pluripotency maintenance by regulating cell cycle phase distribution in mouse embryonic stem cells. , 2011, Differentiation; research in biological diversity.
[36] C. Crumpacker,et al. Silencing p21(Waf1/Cip1/Sdi1) expression increases gene transduction efficiency in primitive human hematopoietic cells. , 2005, Gene therapy.